Hexarelin vs Tesamorelin: What’s the Difference?
The main difference between Hexarelin and Tesamorelin is mechanism: Hexarelin is studied for potent gh release and cardioprotection research — Among the most potent GHS compounds. Tesamorelin is studied for visceral fat reduction research — Stabilized GHRH analog.
Potent GHRP vs visceral-fat-focused GHRH analog.
Key differences between Hexarelin and Tesamorelin
- •Mechanism: Hexarelin — Among the most potent GHS compounds. Tesamorelin — Stabilized GHRH analog.
- •Primary research focus: Hexarelin is studied for potent gh release and cardioprotection research; Tesamorelin is studied for visceral fat reduction research.
- •Depth of human research: Hexarelin — Moderate; Tesamorelin — Strong.
- •Typical study cadence cited in the literature: Hexarelin — 2–3× daily; Tesamorelin — Daily, typically evening.
| Attribute | Hexarelin Hexapeptide GH secretagogue | Tesamorelin Stabilized GHRH analog |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Best known for | Potent GH release and cardioprotection research | Visceral fat reduction research |
| Mechanism of action | Among the most potent GHS compounds. Massive GH spike potential. | Stabilized GHRH analog. Notably effective at reducing visceral (abdominal) fat. |
| Human research | Moderate | Strong |
| Animal research | Moderate | Moderate |
| Mechanistic research | Established | Established |
| Study cadence cited | 2–3× daily | Daily, typically evening |
| In plain English | The strongest GH-pulse peptide of the classic GHRPs — but also the one most likely to raise prolactin and cortisol, and develop tolerance. | Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically. |
| How it works | Strongly activates GHSR and also exerts CD36-mediated cardioprotective effects. | Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue. |
| Researchers study | GH secretion, cardiac tissue protection, and post-MI recovery. | Visceral fat reduction, lipid metabolism, and cognitive function in older adults. |
| Internet discussion | Discussed for short, intense research protocols due to tolerance. | Discussed by people specifically targeting belly fat. |
Mechanism and research evidence, side by side
How Hexarelin and Tesamorelin differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
Hexarelin
Among the most potent GHS compounds. Massive GH spike potential.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Moderate
- Animal research
- Moderate
- Mechanistic research
- Established
Aggressive short-term GH elevation
Tesamorelin
Stabilized GHRH analog. Notably effective at reducing visceral (abdominal) fat.
- GHRH and/or ghrelin receptors in the pituitary
- Pulsatile growth hormone release
- Downstream IGF-1, body-composition and recovery endpoints
- Human research
- Strong
- Animal research
- Moderate
- Mechanistic research
- Established
Visceral fat reduction (particularly abdominal), GH/IGF-1 increase
Hexarelin
Potent GH release and cardioprotection research
The strongest GH-pulse peptide of the classic GHRPs — but also the one most likely to raise prolactin and cortisol, and develop tolerance.
Strongly activates GHSR and also exerts CD36-mediated cardioprotective effects.
GH secretion, cardiac tissue protection, and post-MI recovery.
Discussed for short, intense research protocols due to tolerance.
Hexarelin is the most potent classic GHRP with notable cardioprotective research signals.
Tesamorelin
Visceral fat reduction research
Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically.
Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue.
Visceral fat reduction, lipid metabolism, and cognitive function in older adults.
Discussed by people specifically targeting belly fat.
Tesamorelin is the GHRH analog with strongest data for reducing visceral fat specifically.